CompletedPhase 2NCT03456882
The Effect of RNS60 on ALS Biomarkers
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Principal Investigator
- Ettore Beghi, MDIRCCS Istituto di ricerche farmacologiche Mario Negri di Milano
- Intervention
- RNS60(drug)
- Enrollment
- 147 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2017 – 2021
Study locations (23)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Azienda Opsedaliera Universitaria Consorziale Policlinico- Università degli studi di Bari, Bari, Italy
- Spedali civili di Brescia, Brescia, Italy
- IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova, Italy
- Azienda Ospedaliera Universitaria POLICLINICO "G. MARTINO", Messina, Italy
- Ospedale San Raffaele, Miano, Italy
- Centro Clinico NEMO - Fondazione Serena Onlus, Milan, Italy
- Presidio Ospedaliero Provinciale - Nuovo Ospedale Civile "S. Agostino Estense", Modena, Italy
- Azienda Ospedaliera Universitaria della Seconda Univ. Degli Studi di Napoli (AOU-SUN), Naples, Italy
- Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy
- Ospedale San Francesco ASSL Nuoro, Nuoro, Italy
- Azienda Ospedaliera di Padova-Università degli studi di Padova, Padua, Italy
- Azienda Ospedaliera Universitaria Policlinico "P Giaccone", Palermo, Italy
- Istituto Neurologico Nazionale "C. Mondino", Pavia, Italy
- Azienda Ospedaliero-Universitaria Pisana,, Pisa, Italy
- +8 more locations on ClinicalTrials.gov
Collaborators
ALS Association · Get Out Onlus
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03456882 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)